Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tadaaki Yamada Kunio Matsumoto Tetsuya Mitsudomi Kenichi Suda |
| Publication date | July 25, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |